TAIWAN · TWSE / TPEx
TWi Biotech.
安成生技 · 6610 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$17.201 month -54.5% · 1 year -52.4%
Directors and supervisors hold161,678,34772.3% of shares issued
Of which pledged0.0%0
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 新陳投資股份有限公司 | Chairman · Director | 42,769,383 | 161,678,347 | 72.31% | — | — |
| 吳怡君 | Chairman (corporate representative) | — | 320,000 | 0.14% | — | — |
| 岳嶽 | Director | — | 0 | — | — | — |
| 陳佳青 | Director (corporate representative) | — | 0 | — | — | — |
| 蔡承恩 | Director (corporate representative) · President | — | 112,000 | 0.05% | — | — |
| 王嘉宗 | Independent director | — | 0 | — | — | — |
| 張森雄 | Independent director | — | 0 | — | — | — |
| 張立言 | Independent director | — | 0 | — | — | — |
| 陳譽尹 | Vice president | — | 42,600 | 0.02% | — | — |
| 李紹銘 | Vice president | — | 28,600 | 0.01% | — | 168,000 |
| 陳志明 | Major shareholder (10%+) | — | 0 | — | — | 161,678,347 |
| 黃麗絹 | Chief accountant | — | 99,437 | 0.04% | — | 7,551 |